Regaal targets 20% starch conversion to value-added products
Key highlights
- Regaal plans to convert about 20% of its estimated 1,100 tonnes-per-day starch output into pure value-added products.
- Regaal expects another 20% of starch output to be converted into glucose.
- Regaal reported product-wise starch value addition of about 10% to 15%, excluding liquid glucose, versus an eventual 30% to 35% objective.
- Regaal said institutional product approvals can take 15 days to 2.5 months and requested 4 to 6 months of operating data before discussing margins.
powered by IRIS

Regaal Resources Limited plans to convert about 20% of its estimated 1,100 tonnes-per-day starch output into pure value-added products, alongside 20% for glucose, management said on the investor call. Projects with deployed capital expenditure were in implementation or commissioning, while the longer-term starch value-addition objective was about 30% to 35%, excluding liquid glucose.
Know Regaal Resources inside out
Results, valuation, peers and who's buying, in one view.
What share of Regaal's starch output will become value-added products?
Regaal plans to convert about 20% of its starch output into pure value-added products. Management set out this allocation against an estimated 1,100 tonnes per day of starch production and separately said about 20% of starch would be converted into glucose. The pure value-added-products allocation is therefore distinct from the glucose stream.
Regaal described current product-wise starch value addition, excluding liquid glucose, at approximately 10% to 15%. It put the current figure at around 17% when measured on total volume. Management said projects supporting this expansion already have deployed capital expenditure and are in implementation or commissioning rather than only at the planning stage.
Management said it would use about 30% as the practical reference point within the 30% to 35% eventual range for starch value addition excluding liquid glucose. The stated objective is broader than the initial 20% pure value-added-products allocation because it describes the intended overall level of starch value addition as the commissioned projects develop.
How does Regaal's production base support the conversion plan?
Regaal said its 1,650 tonnes-per-day figure refers to maize grinding capacity rather than finished-product output. Management estimated that processing this volume produces about 1,500 tonnes per day of finished products, including approximately 375 tonnes per day of germ, fibre and gluten. These co-products are sent to the oil and seed processing plant.
After allowing for the co-products, Regaal estimated starch output at around 1,100 tonnes per day. That starch base is the denominator for the planned 20% allocation to glucose and the separate 20% allocation to pure value-added products. The strategy is consequently a change in the mix of starch rather than a claim that 20% of total maize crushing will become pure value-added products.
Regaal also said it has historically operated at more than 95% of capacity and could exceed the stated 1,650 tonnes-per-day grinding level if demand supports it. Management did not provide a new capacity target in the call, but it said the existing site of around 57 acres has some vacant land, including a potential 4 to 5 acres for development.
Got a follow-up? Ask IRIS
Which customer approvals are progressing at Regaal?
Regaal said liquid glucose had received approval from all customers, including Parle, while another product identified by management as MDP had been sent for approval. It also said oxidized starch was already being supplied to other customers and that it had expanded capacity for that product. These comments indicate that approvals and commercial production are proceeding at the same time across different products.
Management said institutional approval can take from 15 days to 2 to 2.5 months for particularly exacting customers. It did not provide an approval schedule by product or name the customers being assessed, other than citing Parle in relation to liquid glucose. The duration therefore describes management's stated approval range, not a commitment for every product.
Regaal said it sells value-added products to institutions as well as smaller customers through dealers, distributors and retailers. Management cited food applications and said it was starting supplies to Wakefield for its premium customers. It said institutional orders can provide larger quantities after samples are approved, while sales through other channels can continue during the approval process.
What has Regaal said about value addition and margins?
Regaal said starch-based value-added products can deliver 50% to 60% value addition and, for some products, as much as 70%, depending on the product. Management added that higher value addition is associated with lower quantities, while product volumes differ across the portfolio. The figures refer to value addition at the product level, not to an assured increase in company-wide profitability.
Regaal did not provide a range for earnings before interest, tax, depreciation and amortisation margin from the expanded portfolio. When asked whether the margin could increase by 2% to 5% or more, management said it could not promise a figure before demand, sales volumes and realised prices were known. It asked for 4 to 6 months after value-added operations are fully started or established before providing more detail.
That response leaves the conversion plan measurable in production mix and approvals, but not yet in reported margin outcomes. Management's comments establish that pricing and demand will determine the eventual financial effect, particularly because the products with the highest stated value addition may carry lower quantities.
When will Regaal begin dextrose production?
Regaal said its dextrose plant is in place but dextrose production has not yet started. Management identified sorbitol as a product made from dextrose, but said sorbitol was not included in current planning. No commissioning date, output target or customer-approval timetable for dextrose was disclosed on the call.
For the current programme, Regaal said it is stabilising the base it has built and working on cost reduction, efficiency, power consumption and packaging costs. Management said work on dextrose is continuing and described 2028 as the focus horizon for its current efforts. This places dextrose within a multi-year operating programme rather than a quantified near-term production commitment.
Conclusion
Regaal's plan divides the output from its maize-processing system into co-products, starch, glucose and pure value-added derivatives. From estimated starch output of about 1,100 tonnes per day, management plans to allocate about 20% to pure value-added products and another 20% to glucose. Its current 10% to 15% product-wise starch value-addition level, excluding liquid glucose, remains below the eventual 30% to 35% objective.
The next measures to watch are the pace of customer approvals, which management placed at 15 days to 2.5 months, and the operating data that management said it needs for 4 to 6 months before discussing margins. Regaal is also focused on stabilising its installed base, reducing power and packaging costs, and progressing dextrose as part of its stated focus through 2028.


